Everest Medicines

Anti-Infectives; Oncology


HBM contact: Dr Ivo Staijen, Dr Emil Bujak

Company status: public

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171